| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/2004 | CN1167387C Spine distraction implant |
| 09/22/2004 | CN1167358C Nutritional composition for treating pressure ulcers |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794544 Method for the preparation of tetrahydrobenzothiepines |
| 09/21/2004 | US6794541 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794490 Lipopeptides as antibacterial agents |
| 09/21/2004 | US6794416 Treatment of chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in humans that smoke or smoked cigarettes using aerosol or nebulizing device with or without concommitant treatment |
| 09/21/2004 | US6794415 Biphenyl compounds and their use as oestrogenic agents |
| 09/21/2004 | US6794413 Compounds and related methods for inhibition of γ-aminobutyric acid aminotransferase |
| 09/21/2004 | US6794412 Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin |
| 09/21/2004 | US6794411 Drinkable ibuprofen pharmaceutical suspension |
| 09/21/2004 | US6794410 Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| 09/21/2004 | US6794409 Homosteroids such as 17-chloro-17a-alpha-ethinyl-17a, 18a-dihomo-estra-1,3,5(10),16-tetraene-3,17a beta-diol; without use of progestin; contraception; for treatment of proliferative diseases of the ovary |
| 09/21/2004 | US6794407 Methods for treating circadian rhythm phase disturbances |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794399 Beta-adrenoreceptor and calcium channel blocking agent; induced vasorelaxing effect |
| 09/21/2004 | US6794398 Preventive/remedies for liver diseases |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794396 Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity |
| 09/21/2004 | US6794395 Substituted indolinones, their manufacture and their use as medicaments |
| 09/21/2004 | US6794393 Tyrosine kinase inhibitors |
| 09/21/2004 | US6794391 Inhibitors of phosphodiesterase (pde) isoenzymes; useful for treatment of respiratory disorders such as asthma. |
| 09/21/2004 | US6794388 Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794384 Hydroxylation activated drug release |
| 09/21/2004 | US6794383 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794381 Succinoylamino lactams as inhibitors of aβ protein |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794375 Palatable arginine compounds and uses thereof for cardiovascular health |
| 09/21/2004 | US6794374 Rheumatoid arthritis, osteoarthritis, or fibromyalgia treatment |
| 09/21/2004 | US6794373 Contraceptive methods using benzimidazolones |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/21/2004 | US6794371 Aminoalkylenephosphonates for treatment of bone disorders |
| 09/21/2004 | US6794370 Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
| 09/21/2004 | US6794368 Composition and method for inducing apoptosis in prostate cancer cells |
| 09/21/2004 | US6794367 Solid preparations for oral administration of drugs relating to genes |
| 09/21/2004 | US6794366 Macrolide antiinfective agents |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794154 Comprises assaying a test substance for the activity of up-regulating the expression of liver-type fatty acid-binding protein (l-fabp) in animal cells; peroxisome proliferator-activated receptor agonists; |
| 09/21/2004 | US6793943 Health food products |
| 09/21/2004 | US6793942 An analgesic, antiinflammatory pharmaceutical and a nutraceutical in a base at least one of which treats a condition caused by an immune response that triggers the cough reflex |
| 09/21/2004 | US6793938 Sustained drug release |
| 09/21/2004 | US6793936 Delivers an active ingredient in a pulsed or bimodal manner. |
| 09/21/2004 | US6793932 Includes at least one keratolytic and cerumenilytic cleaning agent, one bactericide agent, one yeast control agent and one anti-irritant and anti-pruriginous agent; for ear hygiene and for the prevention of otitis in dogs and cats |
| 09/21/2004 | US6793918 Genetic engineering; insertion of adenovirus vectors into cells |
| 09/21/2004 | US6793915 Cool and dry soft solid antiperspirant |
| 09/21/2004 | US6793912 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 09/21/2004 | CA2317673C Novel allylthiopyridazine derivatives and process for preparing the same |
| 09/21/2004 | CA2294207C Anti-chlamydia agent |
| 09/21/2004 | CA2280587C Growth hormone secretagogues |
| 09/21/2004 | CA2277947C Pyrrolidine derivatives having phospholipase a2 inhibitory activity |
| 09/21/2004 | CA2273272C Immediate release drug delivery forms |
| 09/21/2004 | CA2256718C Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 09/21/2004 | CA2241502C A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anti-inflammatory drugs |
| 09/21/2004 | CA2200316C Imidazole derivative |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/21/2004 | CA2191871C Piperazine derivatives as 5ht1a antagonists |
| 09/21/2004 | CA2189297C Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives |
| 09/21/2004 | CA2167673C Condensed benzazepine derivative and pharmaceutical composition thereof |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/21/2004 | CA2150131C Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity |
| 09/21/2004 | CA2146757C Stabilization of fluorocarbon emulsions |
| 09/21/2004 | CA2114017C Amide tetrazole acat inhibitors |
| 09/21/2004 | CA2100381C N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their preparation and pharmaceutical compositions containing the same |
| 09/21/2004 | CA2094540C Orally-ingestible nutrition compositions having improved palatability |
| 09/21/2004 | CA2076226C Substituted 1-pyrimidinylacetamide compounds |
| 09/21/2004 | CA2028581C Compositions for treating fat deposits in humans |
| 09/17/2004 | CA2457989A1 The use of vitamin b6 to mitigate visual field defects associated with the use of gabaergic drugs in mammals |
| 09/17/2004 | CA2422339A1 A composition to promote weight loss |
| 09/16/2004 | WO2004079326A2 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 09/16/2004 | WO2004078975A1 Novel protein and use thereof |
| 09/16/2004 | WO2004078974A1 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 09/16/2004 | WO2004078962A1 Mobile genetic elements belonging to the mariner family in hydrothermal eukaryotes |
| 09/16/2004 | WO2004078941A2 Modulation of gene expression using dna-rna hybrids |
| 09/16/2004 | WO2004078940A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 09/16/2004 | WO2004078928A2 T cell regulation |
| 09/16/2004 | WO2004078925A2 Methods and compositions for treating and preventing neurodegenerative diseases |
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078920A2 Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (kca) |
| 09/16/2004 | WO2004078791A1 Method to produce a solid form of heparin |
| 09/16/2004 | WO2004078789A1 Novel agent for stimulating the release of beta-endorphins, cosmetic and/or dermatological compositions containing same and uses thereof |
| 09/16/2004 | WO2004078771A1 2-fluoro-6-o-substituted ketolide derivative |
| 09/16/2004 | WO2004078764A1 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 09/16/2004 | WO2004078760A1 SUBSTITUTED 8'-PYRIDINYL-DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDO [1,2-a] PYRIMIDIN-6-ONE AND 8'-PYRIMIDINYL-DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDO [1,2-a] PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES |
| 09/16/2004 | WO2004078759A1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/16/2004 | WO2004078758A1 Novel fused heterocycles and uses thereof |
| 09/16/2004 | WO2004078756A2 Jnk inhibitors |
| 09/16/2004 | WO2004078755A1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors |
| 09/16/2004 | WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |